D. E. Shaw & Co., Inc. Stereotaxis, Inc. Transaction History

D. E. Shaw & Co., Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.85 - $2.71 $209,133 - $306,351	-113,045 Reduced 56.72%	86,250 $175,000
Q4 2022 Feb 14, 2023	BUY	$1.55 - $2.38 $108,097 - $165,981	69,740 Added 53.83%	199,295 $412,000
Q3 2022 Nov 14, 2022	SELL	$1.75 - $2.62 $140,920 - $210,978	-80,526 Reduced 38.33%	129,555 $233,000
Q2 2022 Aug 15, 2022	BUY	$1.75 - $3.71 $367,641 - $779,400	210,081 New	210,081 $387,000
Q4 2021 Feb 14, 2022	SELL	$5.14 - $6.84 $383,094 - $509,798	-74,532 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.34 - $9.87 $271,026 - $500,941	50,754 Added 213.45%	74,532 $401,000
Q2 2021 Aug 16, 2021	BUY	$6.41 - $10.17 $152,416 - $241,822	23,778 New	23,778 $229,000

41.1M

139K

20.6K

Ticker STXS
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,790,096
Market Cap $181M
Description
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.